SEC Company Response from Forma Therapeutics Holdings, Inc. (CIK 0001538927) — Jun 16, 2020
Forma Therapeutics Holdings, Inc. (CIK 0001538927)
Date: June 16, 2020 · CIK: 0001538927 · Accession: 0001193125-20-170371
AI Filing Summary & Sentiment
File numbers found in text: 333-238783
Letter
VIA EDGAR Office of Healthcare and Insurance Division of Corporation Finance United States Securities and Exchange Commission Attention: Re: Forma Therapeutics Holdings, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-238783
Dear Ms. Paik,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Forma Therapeutics Holdings, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 18, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Gabriela Morales-Rivera, by facsimile to (617) 801-8858.
If you have any questions regarding this request, please contact Gabriela Morales-Rivera of Goodwin Procter LLP at (617) 570-1329.
Sincerely,
FORMA THERAPEUTICS HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR June 16, 2020 Office of Healthcare and Insurance Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Irene Paik Christie Wong Angela Connell Re: Forma Therapeutics Holdings, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-238783 Dear Ms. Paik, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Forma Therapeutics Holdings, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 18, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Gabriela Morales-Rivera, by facsimile to (617) 801-8858. If you have any questions regarding this request, please contact Gabriela Morales-Rivera of Goodwin Procter LLP at (617) 570-1329. Sincerely, FORMA THERAPEUTICS HOLDINGS, INC. /s/ Frank D. Lee Frank D. Lee President and Chief Executive Officer cc: Jeannette Potts, Forma Therapeutics Holdings, Inc. Todd Shegog, Forma Therapeutics Holdings, Inc. William D. Collins, Esq., Goodwin Procter LLP Sarah Ashfaq, Esq., Goodwin Procter LLP